131
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Influence of Diabetic Retinopathy on the Relationship Between Body Mass Index and Mortality in Patients with Poorly Controlled Type 2 Diabetes

, & ORCID Icon
Pages 907-914 | Published online: 24 Mar 2020

References

  • Chen Y, Copeland WK, Vedanthan R, et al. Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium. BMJ. 2013;347:f5446. doi:10.1136/bmj.f5446
  • Farag YM, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26:28–35. doi:10.1093/ndt/gfq576
  • Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308:581–590. doi:10.1001/jama.2012.9282
  • Kuo JF, Hsieh YT, Mao IC, Lin SD, Tu ST, Hsieh MC. The association between body mass index and all-cause mortality in patients with Type 2 diabetes mellitus: a 5.5-year prospective analysis. Medicine. 2015;94:e1398. doi:10.1097/MD.0000000000001398
  • Thomas G, Khunti K, Curcin V, et al. Obesity paradox in people newly diagnosed with Type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab. 2014;16:317–325. doi:10.1111/dom.12217
  • Costanzo P, Cleland JG, Pellicori P, et al. The obesity paradox in Type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Intern Med. 2015;162:610–618. doi:10.7326/M14-1551
  • Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233–244. doi:10.1056/NEJMoa1304501
  • Dallongeville J, Bhatt DL, Steg PH, et al. Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry. Eur J Prev Cardiol. 2012;19:241–249. doi:10.1177/1741826710394305
  • Jenkins DA, Bowden J, Robinson HA, et al. Adiposity-mortality relationships in Type 2 diabetes, coronary heart disease and cancer subgroups in the UK biobank, and their modification by smoking. Diabetes Care. 2018;41:1878–1886. doi:10.2337/dc17-2508
  • Tobias DK. Addressing reverse causation bias in the obesity paradox is not “One size fits all”. Diabetes Care. 2017;40:1000–1001. doi:10.2337/dci17-0010
  • Edqvist J, Rawshani A, Adiels M, et al. BMI and mortality in patients with new-onset Type 2 diabetes: a comparison with age- and sex-matched control subjects from the general population. Diabetes Care. 2018;41(3):485–493. doi:10.2337/dc17-1309
  • Kwon Y, Kim HJ, Park S, Park YG, Cho KH. Body mass index-related mortality in patients with Type 2 diabetes and heterogeneity in obesity paradox studies: a dose-response meta-analysis. PLoS One. 2017;12:e0168247. doi:10.1371/journal.pone.0168247
  • Lee EY, Lee YH, Yi SW, Shin SA, Yi JJ. BMI and all-cause mortality in normoglycemia, impaired fasting glucose, newly diagnosed diabetes, and prevalent diabetes: a cohort study. Diabetes Care. 2017;40:1026–1033. doi:10.2337/dc16-1458
  • Xing Z, Pei J, Huang J, Peng X, Chen P, Hu X. Relationship of obesity to adverse events among patients with mean 10-year history of type 2 diabetes mellitus: results of the ACCORD study. J Am Heart Assoc. 2018;7:e010512. doi:10.1161/JAHA.118.010512
  • Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with Type 2 diabetes. N Engl J Med. 2018;379:633–644. doi:10.1056/NEJMoa1800256
  • Shah R, Gayat E, Januzzi JL Jr., et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. 2014;63:778–785. doi:10.1016/j.jacc.2013.09.072
  • De Schutter A, Lavie CJ, Kachur S, Patel DA, Milani RV. Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox. Mayo Clin Proc. 2014;89:1072–1079. doi:10.1016/j.mayocp.2014.04.025
  • Kim H, Kim H, Lee M, et al. The impact of disease severity on paradoxical association between body mass index and mortality in patients with acute kidney injury undergoing continuous renal replacement therapy. BMC Nephrol. 2018;19:32. doi:10.1186/s12882-018-0833-5
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–735. doi:10.1053/j.ajkd.2014.01.416
  • WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. doi:10.1016/S0140-6736(03)15268-3
  • Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr. 2004;79:31–39. doi:10.1093/ajcn/79.1.31
  • Zhao W, Katzmarzyk PT, Horswell R, et al. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation. 2014;130:2143–2151. doi:10.1161/CIRCULATIONAHA.114.009098
  • Salinero-Fort MA, San Andres-Rebollo FJ, Gomez-Campelo P, et al. Body mass index and all-cause mortality among type 2 diabetes mellitus patients: findings from the 5-year follow-up of the MADIABETES cohort. Eur J Intern Med. 2017;43:46–52. doi:10.1016/j.ejim.2017.06.021
  • Flegal KM, Ioannidis JPA. The obesity paradox: a misleading term that should be abandoned. Obesity. 2018;26:629–630. doi:10.1002/oby.22140
  • Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39:578–584. doi:10.1016/S0735-1097(01)01802-2
  • Lin CC, Li CI, Liu CS, et al. Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: retrospective cohort studies. Diabetes Metab. 2019;45:564–572. doi:10.1016/j.diabet.2019.02.007
  • Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364:719–729. doi:10.1056/NEJMoa1010679
  • Salehidoost R, Mansouri A, Amini M, Yamini SA, Aminorroaya A. Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta Diabetol. 2018;55:569–577. doi:10.1007/s00592-018-1126-y
  • Kim CH, Kim HK, Kim EH, Bae SJ, Park JY. Relative contributions of insulin resistance and beta-cell dysfunction to the development of Type 2 diabetes in Koreans. Diabet Med. 2013;30:1075–1079. doi:10.1111/dme.12201
  • De Rosa M, Gambardella J, Shu J, Santulli G. Dietary fat is a key determinant in balancing mitochondrial dynamics in heart failure: a novel mechanism underlying the obesity paradox. Cardiovasc Res. 2018;114:925–927. doi:10.1093/cvr/cvy074
  • Fujii N, Nozawa T, Igawa A, et al. Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H760–H766. doi:10.1152/ajpheart.00734.2003
  • Cairelli MJ, Miller CM, Fiszman M, Workman TE, Rindflesch TC. Semantic MEDLINE for discovery browsing: using semantic predications and the literature-based discovery paradigm to elucidate a mechanism for the obesity paradox. AMIA Annu Symp Proc. 2013;2013:164–173.
  • Legchenko E, Chouvarine P, Borchert P, et al. PPARgamma agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation. Sci Transl Med. 2018;10:eaao0303. PMID: 29695452. doi:10.1126/scitranslmed.aao0303
  • Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care. 2011;34:1238–1244. doi:10.2337/dc11-0079
  • Sabanayagam C, Chee ML, Banu R, et al. Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population. JAMA Netw Open. 2019;2:e191540. doi:10.1001/jamanetworkopen.2019.1540
  • Hsieh YM, Lee WJ, Sheu WH, Li YH, Lin SY, Lee IT. Inpatient screening for albuminuria and retinopathy to predict long-term mortality in type 2 diabetic patients: a retrospective cohort study. Diabetol Metab Syndr. 2017;9:29. doi:10.1186/s13098-017-0229-x
  • Song SJ. Obesity and diabetic retinopathy: new perspectives. JAMA Ophthalmol. 2016;134:258. doi:10.1001/jamaophthalmol.2015.5178
  • Zhu W, Wu Y, Meng YF, Xing Q, Tao JJ, Lu J. Association of obesity and risk of diabetic retinopathy in diabetes patients: a meta-analysis of prospective cohort studies. Medicine. 2018;97:e11807. doi:10.1097/MD.0000000000011807
  • Moh A, Neelam K, Zhang X, et al. Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes. Endocr Res. 2018;43(3):186–194. doi:10.1080/07435800.2018.1451541
  • Man RE, Sabanayagam C, Chiang PP, et al. Differential association of generalized and abdominal obesity with diabetic retinopathy in Asian patients with Type 2 diabetes. JAMA Ophthalmol. 2016;134:251–257. doi:10.1001/jamaophthalmol.2015.5103
  • Sasongko MB, Widyaputri F, Sulistyoningrum DC, et al. Estimated resting metabolic rate and body composition measures are strongly associated with diabetic retinopathy in Indonesian adults with Type 2 diabetes. Diabetes Care. 2018;41:2377–2384. doi:10.2337/dc18-1074
  • Chan JCY, Chee ML, Tan NYQ, Cheng CY, Wong TY, Sabanayagam C. Differential effect of body mass index on the incidence of diabetes and diabetic retinopathy in two Asian populations. Nutr Diabetes. 2018;8:16. doi:10.1038/s41387-018-0018-0
  • Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361–369. doi:10.1016/S2213-8587(18)30051-2
  • Lu J, Hou X, Zhang L, et al. Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes. Acta. Diabetol. 2015;52:701–708.
  • Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000;77:S113–S119. doi:10.1046/j.1523-1755.2000.07718.x
  • Matsudaira K, Maeda K, Okumura N, et al. Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical outcome. Results from the Nagoya acute myocardial infarction study. Circ J. 2012;76:1509–1516. doi:10.1253/circj.CJ-11-1127
  • Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping america’s health: association for weight management and obesity prevention; NAASO, the obesity society; the American society for nutrition; and the American diabetes association. Obesity. 2007;15:1061–1067. doi:10.1038/oby.2007.632